Ten Years of Progress in Head and Neck Cancers

Overview

Journal J Natl Compr Canc Netw

Specialty Oncology

Date 2012 Jul 10

PMID 22773796

Citations 22

Authors

Shrujal Baxi

Matthew Fury

Ian Ganly

Shyam Rao

David G Pfister

Affiliations

Soon will be listed here.

Citing Articles

Nutritional status and post-operative complications in patients undergoing surgery for advanced pharyngeal or laryngeal cancer.

Brown T, Edwards A, Pashley A, Lehn B, Vasani S, Hodge R Eur Arch Otorhinolaryngol. 2023; 280(12):5531-5538.

PMID: 37535080 PMC: 10620302. DOI: 10.1007/s00405-023-08139-x.

Transcriptional analysis links B cells and TERT expression to favorable prognosis in head and neck cancer.

Xian S, Dosset M, Castro A, Carter H, Zanetti M PNAS Nexus. 2023; 2(3):pgad046.

PMID: 36909826 PMC: 10003760. DOI: 10.1093/pnasnexus/pgad046.

Promoter Methylation of Cancer Stem Cell Surface Markers as an Epigenetic Biomarker for Prognosis of Oral Squamous Cell Carcinoma.

Han Y, Park H, Park S, Hwang J, Park H, Yi J Int J Mol Sci. 2022; 23(23).

PMID: 36498950 PMC: 9737199. DOI: 10.3390/ijms232314624.

Implications and Emerging Therapeutic Avenues of Inflammatory Response in HPV+ Head and Neck Squamous Cell Carcinoma.

Castellano L, Cruz S, Hier M, Bonan P, Alaoui-Jamali M, da Silva S Cancers (Basel). 2022; 14(21).

PMID: 36358823 PMC: 9657300. DOI: 10.3390/cancers14215406.

Adipose-derived stem cells promote the proliferation, migration, and invasion of oral squamous cell carcinoma cells by activating the Wnt/planar cell polarity signaling pathway.

Li Z, Wang S, Fang S, Li X, Li Y, Liu G Transl Cancer Res. 2022; 11(2):306-315.

PMID: 35281413 PMC: 8904952. DOI: 10.21037/tcr-21-1637.

References

Rischin D, Young R, Fisher R, Fox S, Le Q, Peters L . Prognostic significance of p16INK4A and human papillomavirus in patients with oropharyngeal cancer treated on TROG 02.02 phase III trial. J Clin Oncol. 2010; 28(27):4142-8. PMC: 2953971. DOI: 10.1200/JCO.2010.29.2904. View

Bernier J, Cooper J, Pajak T, Van Glabbeke M, Bourhis J, Forastiere A . Defining risk levels in locally advanced head and neck cancers: a comparative analysis of concurrent postoperative radiation plus chemotherapy trials of the EORTC (#22931) and RTOG (# 9501). Head Neck. 2005; 27(10):843-50. DOI: 10.1002/hed.20279. View

Pointreau Y, Garaud P, Chapet S, Sire C, Tuchais C, Tortochaux J . Randomized trial of induction chemotherapy with cisplatin and 5-fluorouracil with or without docetaxel for larynx preservation. J Natl Cancer Inst. 2009; 101(7):498-506. DOI: 10.1093/jnci/djp007. View

Hammarstedt L, Lindquist D, Dahlstrand H, Romanitan M, Dahlgren L, Joneberg J . Human papillomavirus as a risk factor for the increase in incidence of tonsillar cancer. Int J Cancer. 2006; 119(11):2620-3. DOI: 10.1002/ijc.22177. View

Vermorken J, Remenar E, van Herpen C, Gorlia T, Mesia R, Degardin M . Cisplatin, fluorouracil, and docetaxel in unresectable head and neck cancer. N Engl J Med. 2007; 357(17):1695-704. DOI: 10.1056/NEJMoa071028. View

Bonner J, Harari P, Giralt J, Cohen R, Jones C, Sur R . Radiotherapy plus cetuximab for locoregionally advanced head and neck cancer: 5-year survival data from a phase 3 randomised trial, and relation between cetuximab-induced rash and survival. Lancet Oncol. 2009; 11(1):21-8. DOI: 10.1016/S1470-2045(09)70311-0. View

Vermorken J, Mesia R, Rivera F, Remenar E, Kawecki A, Rottey S . Platinum-based chemotherapy plus cetuximab in head and neck cancer. N Engl J Med. 2008; 359(11):1116-27. DOI: 10.1056/NEJMoa0802656. View

Gillison M, Koch W, Capone R, Spafford M, Westra W, Wu L . Evidence for a causal association between human papillomavirus and a subset of head and neck cancers. J Natl Cancer Inst. 2000; 92(9):709-20. DOI: 10.1093/jnci/92.9.709. View

Ang K, Harris J, Wheeler R, Weber R, Rosenthal D, Nguyen-Tan P . Human papillomavirus and survival of patients with oropharyngeal cancer. N Engl J Med. 2010; 363(1):24-35. PMC: 2943767. DOI: 10.1056/NEJMoa0912217. View

10.

Eisbruch A, Marsh L, Martel M, Ship J, Haken R, Pu A . Comprehensive irradiation of head and neck cancer using conformal multisegmental fields: assessment of target coverage and noninvolved tissue sparing. Int J Radiat Oncol Biol Phys. 1998; 41(3):559-68. DOI: 10.1016/s0360-3016(98)00082-0. View

11.

Genden E, Desai S, Sung C . Transoral robotic surgery for the management of head and neck cancer: a preliminary experience. Head Neck. 2008; 31(3):283-9. DOI: 10.1002/hed.20972. View

12.

Chan A, Liebsch N . Proton radiation therapy for head and neck cancer. J Surg Oncol. 2008; 97(8):697-700. DOI: 10.1002/jso.21013. View

13.

Weinstein G, OMalley Jr B, Snyder W, Sherman E, Quon H . Transoral robotic surgery: radical tonsillectomy. Arch Otolaryngol Head Neck Surg. 2007; 133(12):1220-6. DOI: 10.1001/archotol.133.12.1220. View

14.

Ha P, Califano J . The role of human papillomavirus in oral carcinogenesis. Crit Rev Oral Biol Med. 2004; 15(4):188-96. DOI: 10.1177/154411130401500402. View

15.

Pignon J, Le Maitre A, Maillard E, Bourhis J . Meta-analysis of chemotherapy in head and neck cancer (MACH-NC): an update on 93 randomised trials and 17,346 patients. Radiother Oncol. 2009; 92(1):4-14. DOI: 10.1016/j.radonc.2009.04.014. View

16.

Posner M, Hershock D, Blajman C, Mickiewicz E, Winquist E, Gorbounova V . Cisplatin and fluorouracil alone or with docetaxel in head and neck cancer. N Engl J Med. 2007; 357(17):1705-15. DOI: 10.1056/NEJMoa070956. View

17.

Hafkamp H, Manni J, Haesevoets A, Voogd A, Schepers M, Bot F . Marked differences in survival rate between smokers and nonsmokers with HPV 16-associated tonsillar carcinomas. Int J Cancer. 2008; 122(12):2656-64. DOI: 10.1002/ijc.23458. View

18.

Simard E, Ward E, Siegel R, Jemal A . Cancers with increasing incidence trends in the United States: 1999 through 2008. CA Cancer J Clin. 2012; 62(2):118-28. DOI: 10.3322/caac.20141. View

19.

Siegel R, Naishadham D, Jemal A . Cancer statistics, 2012. CA Cancer J Clin. 2012; 62(1):10-29. DOI: 10.3322/caac.20138. View

20.

Chaturvedi A, Engels E, Anderson W, Gillison M . Incidence trends for human papillomavirus-related and -unrelated oral squamous cell carcinomas in the United States. J Clin Oncol. 2008; 26(4):612-9. DOI: 10.1200/JCO.2007.14.1713. View